InvestorsHub Logo

roiresearch

11/17/20 9:49 AM

#333497 RE: Justfactsmam #333491

sounds exciting. thanks for the update

if we are using biorasi as one of the cro's, it seems they have the process down pat to get us into human trials this month in russia

attilathehunt

11/17/20 10:05 AM

#333502 RE: Justfactsmam #333491

Good thoughts! Thank you!

LilyGDog

11/17/20 10:13 AM

#333504 RE: Justfactsmam #333491

Let's go to Russia and get this party started!

Great post JFM.

Go Leo & IPIX!

Expecting IPIX to commence launch of Clinical Human Trials in Eastern Europe ...by end of November or first week in December with feedback on preliminary results very quickly...

wsbc cites Russia as the "Overseas" country and with IPIX (predecessor - B- Absssi trials)having past trials there, I would strongly concur...

If Russia, I would not be surprised we get "approval" shortly after 90(+) (-) patient trial is completed. The $ to be made is not the important factor...It prompts regulatory agencies from other countries to review and look seriously at Brilacidin for regulatory review and approval (including FDA).

Russia likely chosen for being both more responsive (if Putin wants it Putin gets it) and a quicker regulatory review /approval process and much less expensive than U.S. trials. (if the Hospitals charge at all...since they are in such a crises)

As per PR...balance of Clinical trials will be in U.S for seeking FDA approval

wsbc

11/17/20 1:01 PM

#333531 RE: Justfactsmam #333491

NO 'citing'... for the record.

Expecting IPIX to commence launch of Clinical Human Trials in Eastern Europe ...by end of November or first week in December with feedback on preliminary results very quickly...

wsbc cites Russia as the "Overseas" country and with IPIX (predecessor - B- Absssi trials)having past trials there, I would strongly concur...

If Russia, I would not be surprised we get "approval" shortly after 90(+) (-) patient trial is completed. The $ to be made is not the important factor...It prompts regulatory agencies from other countries to review and look seriously at Brilacidin for regulatory review and approval (including FDA).

Russia likely chosen for being both more responsive (if Putin wants it Putin gets it) and a quicker regulatory review /approval process and much less expensive than U.S. trials. (if the Hospitals charge at all...since they are in such a crises)

As per PR...balance of Clinical trials will be in U.S for seeking FDA approval

TheDane

11/17/20 6:55 PM

#333572 RE: Justfactsmam #333491

Unfortunately this would be a taint similar to what happened to hydroxychloroquine because Trump liked it. Who’s going to think of Brilicidin (aka, Puticidin) as a go to drug for anything if it’s from the Rooskies?

Having said that, if Putin can get us on the map and up to $10+ I’ll take it.

(I know...that’s bashing! Brilicidin is worth at least $10 billion!)